Autologous stem cell transplantation for acute myeloid leukemia – a 15 yr single center experience (CROSBI ID 502699)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | domaća recenzija
Podaci o odgovornosti
Sertić, Dubravka ; Nemet, Damir ; Mrsić, Mirando ; Serventi-Seiwerh, Ranka ; Aurer, Igor ; Radman, Ivo ; Zupančić-Šalek, Silva ; Radojčić, Vedran ; Mikulić, Mirta ; Golubić-Ćepulić, Branka ; Bojanić, Ines ; Batinić, Drago ; Mrsić, Sanja ; Boban, Dubravka ; Labar, Boris
engleski
Autologous stem cell transplantation for acute myeloid leukemia – a 15 yr single center experience
From April 1988 to June 2004 (64 male and 65 female) patients with AML were treated with intensive therapy followed by reinfusion of autologous stem cell. Autologous stem cell transplantation is a standard post- remission treatment for AML patients without HLA identical donor. Relapse rate was significantly lower in patients autografted in 1st CR compared to patients received autologous stem cells in >1st CR.
AML; autologous stem cell transplantation
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
147-x.
2004.
objavljeno
Podaci o matičnoj publikaciji
Abstract Book
Zagreb:
Podaci o skupu
7th seminar New trends in the treatment of acute leukemia
poster
11.09.2004-14.09.2004
Dubrovnik, Hrvatska
